Publication
  • SOHO •
  • 4 September, 2025 •
  • •

Cytopenia is associated with real-world disease progression and diminished survival in patients with myelofibrosis: Analysis of a US national administrative claims database

Lindsay AM Rein, Nicole M Engel-Nitz, Michael Marrone, Jeffrey McPheeters, Abiola Oladapo, Purvi Suthar, Michael Vredenburg , Yong Zhu, Aaron T Gerds, Lucia Masarova

Available materials

Poster
Publication
  • SOHO •
  • 4 September, 2025 •
  • •

Hematologic response in patients with myelofibrosis treated with pacritinib in real-word clinical settings

Raajit Rampal, Samantha Eiffert, Michael Marrone, Lisa Morere, Abiola Oladapo, Purvi Suthar, Anupama Vasudevan, Michael Vredenburg , John Mascarehnas

Available materials

Poster
Publication
  • EHA •
  • 15 June, 2025 •
  • •

Real-World Treatment Patterns and Clinical Outcomes in Patients with Myelofibrosis Treated with Pacritinib (PAC) with platelets ≥50 x10^9/L at PAC initiation: Interim results from the MY-PAC Study

Doug Tremblay, Abiola Oladapo, Emily Levine, Michael Marrone, Djibril Liassou, Purvi Suthar, Adina Geprifti, Gerard Hoehn, Michael Vredenburg , Bruce Feinberg, Naveen Pemmaraju, James Rossetti

Available materials

Poster
Publication
  • EHA •
  • 15 June, 2025 •
  • •

Real-world effectiveness of pacritinib in patients with myelofibrosis who have thrombocytopenia and anemia

Raajit Rampal, Samantha Eiffert, Michael Marrone, Lisa Morere, Abiola Oladapo, Anubhav Sharma, Purvi Suthar, Anupama Vasudevan, Michael Vredenburg , John Mascarenhas

Available materials

Poster
Publication
  • EHA •
  • 15 June, 2025 •
  • •

Economic Burden of Cytopenia in Patients with Myelofibrosis: Analysis of a US National Administrative Claims Database

Aaron T Gerds, Lucia Masarova, Nicole M Engel-Nitz, Michael Marrone, Jefferey McPheeters, Abiola Oladapo, Purvi Suthar, Michael Vredenburg , Yong Zhu, Lindsay AM Rein

Available materials

Poster
Publication
  • EHA •
  • 13 June, 2025 •
  • •

Transfusion-related cost and time burden offsets in patients with myelofibrosis treated with pacritinib compared to best available therapy based on PERSIST-2 trial

Abiola Oladapo, Karisse Roman-Torres, Aaron T Gerds, Stephen T. Oh

Available materials

Poster
Sign up for alerts